Clinical Trials Browser

Phase 3 × Lymphoma, T-Cell × Alemtuzumab × Clear all

NCT00646854 2019-03-01

ACT-1

Phase 3 Completed

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT00725231 2012-05-07

A-CHOP-14

Phase 3 Unknown

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell